-
Je něco špatně v tomto záznamu ?
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
N. Gökbuget, N. Boissel, S. Chiaretti, H. Dombret, M. Doubek, A. Fielding, R. Foà, S. Giebel, D. Hoelzer, M. Hunault, DI. Marks, G. Martinelli, O. Ottmann, A. Rijneveld, P. Rousselot, J. Ribera, R. Bassan
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy, směrnice pro lékařskou praxi
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
ROAD: Directory of Open Access Scholarly Resources
PubMed
38306595
DOI
10.1182/blood.2023023568
Knihovny.cz E-zdroje
- MeSH
- akutní lymfatická leukemie * terapie diagnóza MeSH
- dospělí MeSH
- lidé MeSH
- management nemoci MeSH
- prognóza MeSH
- reziduální nádor diagnóza terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.
Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic
Department of Medicine 2 Hematology Oncology Goethe University University Hospital Frankfurt Germany
Division of Cancer and Genetics Cardiff University School of Medicine Cardiff United Kingdom
Division of Hematology Ospedale dell'Angelo Mestre Venice Italy
Erasmus MC Cancer Institute Rotterdam The Netherlands
Hematology Department of Translational and Precision Medicine Sapienza University Rome Italy
Hospital Saint Louis Assistance Publique Hôpitaux de Paris Paris France
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Meldola Italy
UCL Cancer Institute London United Kingdom
University Hospitals Bristol NHS Foundation Trust Bristol United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013970
- 003
- CZ-PrNML
- 005
- 20240905133323.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1182/blood.2023023568 $2 doi
- 035 __
- $a (PubMed)38306595
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gökbuget, Nicola $u Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany $1 https://orcid.org/0000000322918245
- 245 10
- $a Management of ALL in adults: 2024 ELN recommendations from a European expert panel / $c N. Gökbuget, N. Boissel, S. Chiaretti, H. Dombret, M. Doubek, A. Fielding, R. Foà, S. Giebel, D. Hoelzer, M. Hunault, DI. Marks, G. Martinelli, O. Ottmann, A. Rijneveld, P. Rousselot, J. Ribera, R. Bassan
- 520 9_
- $a Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a akutní lymfatická leukemie $x terapie $x diagnóza $7 D054198
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a reziduální nádor $x diagnóza $x terapie $7 D018365
- 650 _2
- $a prognóza $7 D011379
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Boissel, Nicolas $u Hospital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France $1 https://orcid.org/0000000320917927
- 700 1_
- $a Chiaretti, Sabina $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
- 700 1_
- $a Dombret, Hervé $u Leukemia Department, University Hospital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Saint-Louis Research Institute, Université Paris Cité, Paris, France
- 700 1_
- $a Doubek, Michael $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000212696282
- 700 1_
- $a Fielding, Adele $u UCL Cancer Institute, London, United Kingdom $1 https://orcid.org/0000000247467789 $7 xx0316854
- 700 1_
- $a Foà, Robin $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
- 700 1_
- $a Giebel, Sebastian $u Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland $1 https://orcid.org/0000000248274401
- 700 1_
- $a Hoelzer, Dieter $u Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany
- 700 1_
- $a Hunault, Mathilde $u Maladies du Sang University Hospital of Angers, FHU Goal, INSERM, National Centre for Scientific Research, Angers, France $1 https://orcid.org/0000000177775216
- 700 1_
- $a Marks, David I $u University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
- 700 1_
- $a Martinelli, Giovanni $u IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy
- 700 1_
- $a Ottmann, Oliver $u Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom
- 700 1_
- $a Rijneveld, Anita $u Erasmus MC Cancer Institute, Rotterdam, The Netherlands
- 700 1_
- $a Rousselot, Philippe $u Clinical Hematology Department, Centre Hospitalier de Versailles, Université Paris-Saclay, Versailles, France
- 700 1_
- $a Ribera, Josep $u Clinical Hematology Department, Institut Catala d'Oncologia Hospital Germans Trias I Pujol, Josep Carreras Research Institute, Badalona, Spain $1 https://orcid.org/0000000310426024
- 700 1_
- $a Bassan, Renato $u Division of Hematology, Ospedale dell'Angelo, Mestre-Venice, Italy $1 https://orcid.org/0000000182142894 $7 xx0317382
- 773 0_
- $w MED00000807 $t Blood $x 1528-0020 $g Roč. 143, č. 19 (2024), s. 1903-1930
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38306595 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133317 $b ABA008
- 999 __
- $a ok $b bmc $g 2143647 $s 1225836
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 143 $c 19 $d 1903-1930 $e 20240509 $i 1528-0020 $m Blood $n Blood $x MED00000807
- LZP __
- $a Pubmed-20240725